Pharmacological management of binge eating disorder: current and emerging treatment options

SL McElroy, AI Guerdjikova, N Mori… - … and Clinical Risk …, 2012 - Taylor & Francis
Growing evidence suggests that pharmacotherapy may be beneficial for some patients with
binge eating disorder (BED), an eating disorder characterized by repetitive episodes of …

Melanin-concentrating hormone: a new sleep factor?

P Torterolo, P Lagos, JM Monti - Frontiers in neurology, 2011 - frontiersin.org
Neurons containing the neuropeptide melanin-concentrating hormone (MCH) are mainly
located in the lateral hypothalamus and the incerto-hypothalamic area, and have …

Recent advance in the pharmacology of dihydropyrimidinone

JP Wan, Y Pan - Mini Reviews in Medicinal Chemistry, 2012 - ingentaconnect.com
Dihydropyrimidinones (DHPMs) are a series of highly valuable small molecules possessing
versatile pharmaceutical properties. Although the first one-pot synthesis of DHPMs had been …

Discovery of (3-(4-(2-oxa-6-azaspiro [3.3] heptan-6-ylmethyl) phenoxy) azetidin-1-yl)(5-(4-methoxyphenyl)-1, 3, 4-oxadiazol-2-yl) methanone (AZD1979), a melanin …

A Johansson, C Lofberg, M Antonsson… - Journal of Medicinal …, 2016 - ACS Publications
A novel series of melanin concentrating hormone receptor 1 (MCHr1) antagonists were the
starting point for a drug discovery program that culminated in the discovery of 103 …

Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists

S Sasmal, G Balaji, HRK Reddy… - Bioorganic & medicinal …, 2012 - Elsevier
Melanin concentrating hormone (MCH) is an important mediator of energy homeostasis and
plays a role in metabolic and CNS disorders. The modeling-supported design, synthesis and …

WDL-RF: predicting bioactivities of ligand molecules acting with G protein-coupled receptors by combining weighted deep learning and random forest

J Wu, Q Zhang, W Wu, T Pang, H Hu, WKB Chan… - …, 2018 - academic.oup.com
Motivation Precise assessment of ligand bioactivities (including IC50, EC50, Ki, Kd, etc.) is
essential for virtual screening and lead compound identification. However, not all ligands …

Depressive-like profile induced by MCH microinjections into the dorsal raphe nucleus evaluated in the forced swim test

P Lagos, J Urbanavicius, MC Scorza… - Behavioural brain …, 2011 - Elsevier
Antagonism of the melanin-concentrating hormone (MCH) receptor 1 (MCH-R1) has been
recently shown to have antidepressant-like profile in rats. However, the mechanisms by …

Alpha-melanocyte-stimulating hormone-mediated appetite regulation in the central nervous system

Q Wu, J Chen, T Hua, J Cai - Neuroendocrinology, 2023 - karger.com
Understanding the complex action mechanism of appetite regulation peptides can
significantly impact therapeutic options in the treatment of obesity and other metabolic …

Immunoneutralization of melanin-concentrating hormone (MCH) in the dorsal raphe nucleus: effects on sleep and wakefulness

P Lagos, P Torterolo, H Jantos, JM Monti - Brain research, 2011 - Elsevier
Hypothalamic neurons that utilize melanin-concentrating hormone (MCH) as a
neuromodulator exert a positive control over energy homeostasis, inducing feeding and …

Precise modelling and interpretation of bioactivities of ligands targeting G protein-coupled receptors

J Wu, B Liu, WKB Chan, W Wu, T Pang, H Hu… - …, 2019 - academic.oup.com
Motivation Accurate prediction and interpretation of ligand bioactivities are essential for
virtual screening and drug discovery. Unfortunately, many important drug targets lack …